Form 4: XPO Inc. Executive Chairman Brad Jacobs Reports Stock Transactions
SEC Form 4 Filing
Brad Jacobs, Executive Chairman of XPO Inc., reports the vesting and conversion of restricted stock units and associated tax withholding.
Summary
- On March 15, 2024, Brad Jacobs, the Executive Chairman of XPO Inc., reported transactions involving XPO common stock.
- These transactions included the vesting of 9,193 Restricted Stock Units (RSUs) and their subsequent conversion into common stock.
- Additionally, 4,261 shares were disposed of to cover tax obligations related to the RSU vesting at a price of $122.66 per share.
- Following these transactions, Jacobs directly owns 415,488 shares of common stock and indirectly owns 1,300,701 shares through Jacobs Private Equity, LLC.
- He also directly owns 18,386 Restricted Stock Units.
Sentiment
Score: 5
Explanation: This is a neutral report on stock transactions by an executive, with no inherent positive or negative implications for the company's performance.
Industry Context
This filing is a routine disclosure of insider transactions, which are common for executives who receive stock-based compensation. It provides transparency into the trading activities of company leadership.
Stakeholder Impact
- The transactions have a minimal impact on shareholders as they represent a small percentage of the total outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 03/15/2024 | Date of RSU vesting and stock transactions. |
| 03/15/2024 | First vesting date for RSUs. |
| 03/15/2025 | Second vesting date for RSUs. |
| 03/15/2026 | Third vesting date for RSUs. |
| 03/19/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.